RSCF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
Capitalization
4.44M
VYCO
Price
$0.13
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
Capitalization
5.84M
Interact to see
Advertisement

RSCF vs VYCO

Header iconRSCF vs VYCO Comparison
Open Charts RSCF vs VYCOBanner chart's image
Reflect Scientific
Price$0.05
Change-$0.00 (-0.00%)
Volume$29.4K
Capitalization4.44M
Vycor Medical
Price$0.13
Change-$0.00 (-0.00%)
Volume$22.67K
Capitalization5.84M
RSCF vs VYCO Comparison Chart in %
Loading...
RSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RSCF vs. VYCO commentary
Sep 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSCF is a Hold and VYCO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 19, 2025
Stock price -- (RSCF: $0.05 vs. VYCO: $0.13)
Brand notoriety: RSCF and VYCO are both not notable
RSCF represents the Pharmaceuticals: Other, while VYCO is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: RSCF: 43% vs. VYCO: 226%
Market capitalization -- RSCF: $4.36M vs. VYCO: $4.01M
RSCF [@Pharmaceuticals: Other] is valued at $4.36M. VYCO’s [@Medical/Nursing Services] market capitalization is $4.01M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $155.76B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.06B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RSCF’s FA Score shows that 1 FA rating(s) are green whileVYCO’s FA Score has 1 green FA rating(s).

  • RSCF’s FA Score: 1 green, 4 red.
  • VYCO’s FA Score: 1 green, 4 red.
According to our system of comparison, VYCO is a better buy in the long-term than RSCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RSCF’s TA Score shows that 4 TA indicator(s) are bullish while VYCO’s TA Score has 4 bullish TA indicator(s).

  • RSCF’s TA Score: 4 bullish, 6 bearish.
  • VYCO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VYCO is a better buy in the short-term than RSCF.

Price Growth

RSCF (@Pharmaceuticals: Other) experienced а -17.78% price change this week, while VYCO (@Medical/Nursing Services) price change was -3.10% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.10%. For the same industry, the average monthly price growth was +2.60%, and the average quarterly price growth was +6.69%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.20%. For the same industry, the average monthly price growth was +8.58%, and the average quarterly price growth was +7.99%.

Industries' Descriptions

@Pharmaceuticals: Other (-1.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+2.20% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYCO($5.84M) has a higher market cap than RSCF($4.44M). VYCO YTD gains are higher at: 150.358 vs. RSCF (23.333). VYCO has higher annual earnings (EBITDA): 87.7K vs. RSCF (8.86K). RSCF has more cash in the bank: 1.3M vs. VYCO (99.7K). RSCF has less debt than VYCO: RSCF (141K) vs VYCO (1.01M). VYCO (1.78M) and RSCF (1.72M) have equivalent revenues.
RSCFVYCORSCF / VYCO
Capitalization4.44M5.84M76%
EBITDA8.86K87.7K10%
Gain YTD23.333150.35816%
P/E RatioN/AN/A-
Revenue1.72M1.78M97%
Total Cash1.3M99.7K1,303%
Total Debt141K1.01M14%
FUNDAMENTALS RATINGS
RSCF vs VYCO: Fundamental Ratings
RSCF
VYCO
OUTLOOK RATING
1..100
5189
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
6542
P/E GROWTH RATING
1..100
3100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYCO's Valuation (22) in the null industry is somewhat better than the same rating for RSCF (68). This means that VYCO’s stock grew somewhat faster than RSCF’s over the last 12 months.

VYCO's Profit vs Risk Rating (100) in the null industry is in the same range as RSCF (100). This means that VYCO’s stock grew similarly to RSCF’s over the last 12 months.

RSCF's SMR Rating (92) in the null industry is in the same range as VYCO (100). This means that RSCF’s stock grew similarly to VYCO’s over the last 12 months.

VYCO's Price Growth Rating (42) in the null industry is in the same range as RSCF (65). This means that VYCO’s stock grew similarly to RSCF’s over the last 12 months.

RSCF's P/E Growth Rating (3) in the null industry is significantly better than the same rating for VYCO (100). This means that RSCF’s stock grew significantly faster than VYCO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSCFVYCO
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
RSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNT70.641.37
+1.98%
Brookfield Wealth Solutions Ltd
SRBK15.050.23
+1.55%
SR Bancorp
RARE29.110.40
+1.39%
Ultragenyx Pharmaceutical
SVRA3.610.01
+0.28%
Savara
BOLT5.34-0.03
-0.56%
Bolt Biotherapeutics Inc

RSCF and

Correlation & Price change

A.I.dvisor tells us that RSCF and VYCO have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCF and VYCO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSCF
1D Price
Change %
RSCF100%
N/A
VYCO - RSCF
21%
Poorly correlated
+40.00%
APDN - RSCF
21%
Poorly correlated
+1.03%
POSC - RSCF
8%
Poorly correlated
-0.32%
SAFLF - RSCF
8%
Poorly correlated
N/A
RYLPF - RSCF
5%
Poorly correlated
N/A
More

VYCO and

Correlation & Price change

A.I.dvisor tells us that VYCO and ZJYL have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VYCO and ZJYL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYCO
1D Price
Change %
VYCO100%
+40.00%
ZJYL - VYCO
24%
Poorly correlated
-1.89%
RSCF - VYCO
21%
Poorly correlated
N/A
XVIPF - VYCO
17%
Poorly correlated
N/A
ZTEK - VYCO
8%
Poorly correlated
-3.02%
OM - VYCO
2%
Poorly correlated
+1.72%
More